CWRUObserver.com -Financial News and Headlines - NYSE, Nasdaq, OTC's

[sublime]

DCTH 4.10 Delcath to Present at the ThinkBIG 2007 Conference Sponsored by ThinkEquity Partners LLC
Jul 26, 2007 8:41:00 AM
Copyright Business Wire 2007

STAMFORD, Conn.--(BUSINESS WIRE)--

Delcath Systems, Inc. (Nasdaq:DCTH) today announced that its Chief Executive Officer, Richard L. Taney, will present at the upcoming ThinkBIG 2007 Conference, a gathering of top performing small cap companies sponsored by ThinkEquity Partners LLC for their institutional investor clients. The Delcath presentation is scheduled for 11:15 AM Eastern Time on Thursday, August 2, 2007. The event will be held at the Mandarin Oriental Hotel in New York City.

About Delcath Systems, Inc.

Delcath Systems is the developer of percutaneous perfusion technology for organ- or region-specific delivery of therapeutic and chemotherapeutic agents. The Delcath system is currently being tested with the drug melphalan in a Phase III trial of patients with metastatic ocular and cutaneous melanoma in the liver, and a Phase II trial of patients with primary liver cancers and metastatic tumors in the liver from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. The Company's intellectual property portfolio currently consists of 12 patents on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website www.delcath.com.

Source: Delcath Systems, Inc.

----------------------------------------------

Company Contact:
Delcath Systems
Inc.
Richard Taney
203-323-8668
www.delcath.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates
Inc.
Anne Marie Fields
212-838-3777
[e-mail]
Bruce Voss
310-691-7100
[e-mail]
www.lhai.com